U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C3H7O4S2.Au
Molecular Weight 368.182
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AUROTIOPROL ACID

SMILES

[Au+].OC(CS)CS([O-])(=O)=O

InChI

InChIKey=ULXIRCUSBPAVNN-UHFFFAOYSA-M
InChI=1S/C3H8O4S2.Au/c4-3(1-8)2-9(5,6)7;/h3-4,8H,1-2H2,(H,5,6,7);/q;+1/p-1

HIDE SMILES / InChI
Molecular Formula Au
Molecular Weight 196.9666
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C3H7O4S2
Molecular Weight 171.215
Charge -1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Aurotioprol acid is a gold salt. It was used as an antirheumatic agent and marketed by Solvay under tradename Allochrysine. Aurotioprol was administered by intramuscular injections.

Approval Year

Unknown
139594
PubMed

PubMed

TitleDatePubMed
Rat anti-glomerular basement membrane antibodies in toxin-induced autoimmunity and in chronic graft-vs.-host reaction share recurrent idiotypes.
1990 Jan
Substance Class Chemical
Created
by admin
on Sat Dec 16 05:40:46 GMT 2023
Edited
by admin
on Sat Dec 16 05:40:46 GMT 2023
Record UNII
DW729GNC8E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AUROTIOPROL ACID
Common Name English
AURATE(1-), (2-HYDROXY-3-MERCAPTO-1-PROPANESULFONATO(2-)-O2,S3)-, HYDROGEN
Common Name English
Code System Code Type Description
FDA UNII
DW729GNC8E
Created by admin on Sat Dec 16 05:40:46 GMT 2023 , Edited by admin on Sat Dec 16 05:40:46 GMT 2023
PRIMARY
CAS
80501-68-4
Created by admin on Sat Dec 16 05:40:46 GMT 2023 , Edited by admin on Sat Dec 16 05:40:46 GMT 2023
PRIMARY
PUBCHEM
71587296
Created by admin on Sat Dec 16 05:40:46 GMT 2023 , Edited by admin on Sat Dec 16 05:40:46 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966